1
|
Carrasco-Garrido P, Hernández-Barrera V, Jiménez-Trujillo I, Lima Florencio L, Gallardo Pino C, Yeamans S, Palacios-Ceña D. Trends in the nonmedical misuse of benzodiazepines and Z-hypnotics among school-aged adolescents (2016-2021): gender differences and related factors. Child Adolesc Ment Health 2024; 29:345-354. [PMID: 38778447 DOI: 10.1111/camh.12716] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 01/31/2024] [Indexed: 05/25/2024]
Abstract
BACKGROUND The misuse of psychotropic medication has increased during the past decade, especially among adolescents. The aim of our study was to describe the prevalence and patterns of the nonmedical use of benzodiazepines (BDZ) and Z-hypnotics among school-aged adolescents through the lens of sex. In addition, we sought to analyze the temporal evolution of the nonmedical use of these drugs during the period 2016-2021. METHODS The temporal evolution of the nonmedical use of these drugs was analyzed based on survey data collected in 2016, 2018 and 2021, which includes the first years of the COVID-19 pandemic. To assess the possible effect of the COVID-19 pandemic, the year at survey was conducted was introduced as a categorical variable. We used data from the Spanish State Survey on Drug Use in Secondary Education, which covers drug use among students aged 14-18 years. Using multivariate logistic regression models, we estimated the independent effect of different variables (sociodemographic data, use of other psychoactive substances, risk perception and availability) on the nonmedical use of BDZ and Z-hypnotics. RESULTS In total, survey data from 95,700 adolescents were included in our analysis. The nonmedical use of BDZ and Z-hypnotics increased among adolescents during the study period. The adjusted odds ratio (AOR) from 2016 to 2018 was 1.11 (95% CI 0.94-1.31) and from 2018 to 2021 the AOR was 1.26 (95% CI 1.08-1.46), using 2016 and 2018, respectively, as reference years. The nonmedical use of BDZ and Z-hypnotics was more likely in adolescent girls than boys (AOR = 2.11). The nonmedical use of prescription opioids (AOR = 3.44), novel psychoactive substances and other illicit psychoactive drugs (AOR = 4.10) were risk factors for the nonmedical use of BDZ and Z-hypnotics in both sexes. Use of cannabis (AOR = 1.38) was a predictor of nonmedical use in female adolescents only. CONCLUSIONS This study shows that the trend of the nonmedical use of BDZ and Z-hypnotics among school-aged adolescents in Spain increased between 2016 and 2021. Among adolescents aged 14 to 18, the probability of nonmedical use of these psychoactive substances was twice as high for female adolescents as for male adolescents.
Collapse
Affiliation(s)
- Pilar Carrasco-Garrido
- Department of Medical Specialties and Public Health, Health Sciences Faculty Universidad Rey Juan Carlos, Madrid, Spain
- Research Group in Epidemiology of Medicines (RESEPMED), Rey Juan Carlos University, Alcorcón, Spain
| | - Valentín Hernández-Barrera
- Department of Medical Specialties and Public Health, Health Sciences Faculty Universidad Rey Juan Carlos, Madrid, Spain
- Research Group in Epidemiology of Medicines (RESEPMED), Rey Juan Carlos University, Alcorcón, Spain
| | - Isabel Jiménez-Trujillo
- Department of Medical Specialties and Public Health, Health Sciences Faculty Universidad Rey Juan Carlos, Madrid, Spain
- Research Group in Epidemiology of Medicines (RESEPMED), Rey Juan Carlos University, Alcorcón, Spain
| | - Lidiane Lima Florencio
- Research Group in Epidemiology of Medicines (RESEPMED), Rey Juan Carlos University, Alcorcón, Spain
- Department of Physical Therapy, Occupational Therapy, Rehabilitation and Physical Medicine, Health Sciences Faculty, Rey Juan Carlos University, Madrid, Spain
| | - Carmen Gallardo Pino
- Department of Medical Specialties and Public Health, Health Sciences Faculty Universidad Rey Juan Carlos, Madrid, Spain
- Research Group in Epidemiology of Medicines (RESEPMED), Rey Juan Carlos University, Alcorcón, Spain
| | - Spencer Yeamans
- Department of Medical Specialties and Public Health, Health Sciences Faculty Universidad Rey Juan Carlos, Madrid, Spain
- Research Group in Epidemiology of Medicines (RESEPMED), Rey Juan Carlos University, Alcorcón, Spain
| | - Domingo Palacios-Ceña
- Research Group in Epidemiology of Medicines (RESEPMED), Rey Juan Carlos University, Alcorcón, Spain
- Department of Physical Therapy, Occupational Therapy, Rehabilitation and Physical Medicine, Health Sciences Faculty, Rey Juan Carlos University, Madrid, Spain
| |
Collapse
|
2
|
Lunghi C, Cailhol L, Massamba V, Renaud S, David P, Laouan Sidi EA, Biskin R, Koch M, Martineau C, Rahme E, Rochette L, Sirois C, Villeneuve E, Vincent P, Lesage A. Cluster B personality disorders and psychotropic medications: a focused analysis of trends and patterns across sex and age groups. Soc Psychiatry Psychiatr Epidemiol 2024:10.1007/s00127-024-02768-1. [PMID: 39287636 DOI: 10.1007/s00127-024-02768-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/03/2024] [Accepted: 09/07/2024] [Indexed: 09/19/2024]
Abstract
PURPOSE This study investigated sex and age differences in patterns of psychotropic medication use before and after the initial diagnosis of Cluster B personality disorders (PDs) and analyzed trends over time. METHODS Analyzing data from the Quebec Integrated Chronic Disease Surveillance System for individuals newly diagnosed with Cluster B PD (≥ 14 years) between 2002 and 2018 and under the provincial public drug plan, we calculated yearly and monthly proportions of individuals exposed to psychotropic medications during the year before and after their diagnosis by sex and age. Robust Poisson regression models assessed the association between sex and exposure to psychotropic medications after the diagnosis of Cluster B PD. RESULTS Among 87,778 individuals with a first Cluster B PD diagnosis (mean age: 44.5 years; 57.5% women), the proportion of users increased post-diagnosis. Notably, after diagnosis, females were more likely to receive psychiatric medications (between 78.9% and 83.7% during the study period vs. 72.8% and 76.8%). Males were less likely than females to receive antidepressants (adjusted prevalence ratio (aPR): 0.83; 99% confidence interval (CI): 0.82-0.85) and anxiolytics (aPR: 0.86; 99%CI: 0.84-0.88), whereas they had higher exposure to antipsychotics (aPR: 1.04; 99%CI: 1.02-1.06) and ADHD medications (aPR: 1.14; 99%CI: 1.07-1.2). Age-specific trends showed increased ADHD medication use among younger patients (14-24 years), and anxiolytic use predominated in those aged ≥ 65 years. CONCLUSIONS Psychotropic medication use was high among Cluster B PD patients, with differences in medication classes according to age and sex. The marked sex and age differences in psychotropic medication use among Cluster B PD patients underscore the need for a sex-sensitive and age-specific approach in psychiatric care.
Collapse
Affiliation(s)
- Carlotta Lunghi
- Department of Medical and Surgical Sciences, Alma Mater University of Bologna, Via Irnerio, 48, 40126, Bologna, Italy.
- Institut National de Santé Publique du Québec, Quebec, QC, Canada.
| | - Lionel Cailhol
- Department of Psychiatry and Research Center, Institut Universitaire de Santé Mentale de Montréal, Montreal, QC, Canada
- Department of Psychiatry and Addiction, Université de Montréal, Montreal, QC, Canada
| | | | - Suzane Renaud
- Department of Psychiatry, Centre Intégré de Santé et de Services Sociaux (CISSS) des Laurentides, Saint-Jérôme, QC, Canada
| | - Pierre David
- Department of Psychiatry and Research Center, Institut Universitaire de Santé Mentale de Montréal, Montreal, QC, Canada
| | | | - Robert Biskin
- Department of Psychiatry, McGill University, Montreal, QC, Canada
| | - Marion Koch
- Department of Psychiatry, McGill University, Montreal, QC, Canada
- Department of Psychiatry, Hôpital de Gatineau, Gatineau, QC, Canada
| | - Cathy Martineau
- Department of Health Sciences, Université du Québec à Rimouski, Lévis, QC, Canada
| | - Elham Rahme
- Department of Medicine, Division of Clinical Epidemiology, McGill University, Montreal, QC, Canada
| | - Louis Rochette
- Institut National de Santé Publique du Québec, Quebec, QC, Canada
| | - Caroline Sirois
- Institut National de Santé Publique du Québec, Quebec, QC, Canada
- Faculty of Pharmacy, Université Laval, Quebec, QC, Canada
| | - Evens Villeneuve
- Faculty of Medicine, Université Laval, Quebec, QC, Canada
- Institut Universitaire en Santé Mentale de Québec, Quebec, QC, Canada
| | - Philippe Vincent
- Faculty of Pharmacy, Université de Montréal, Montreal, QC, Canada
| | - Alain Lesage
- Institut National de Santé Publique du Québec, Quebec, QC, Canada
- Department of Psychiatry and Research Center, Institut Universitaire de Santé Mentale de Montréal, Montreal, QC, Canada
- Department of Psychiatry and Addiction, Université de Montréal, Montreal, QC, Canada
| |
Collapse
|
3
|
Jufresa-Blanch E, Carrilero N, García-Altés A. The influence of general practitioner and patient sex on the treatment of major depression. Front Pharmacol 2023; 14:1274774. [PMID: 38027028 PMCID: PMC10665506 DOI: 10.3389/fphar.2023.1274774] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/08/2023] [Accepted: 10/18/2023] [Indexed: 12/01/2023] Open
Abstract
Introduction: Biological and sociocultural factors may lead to a significant gender bias in the treatment of major depression and thus contribute to accentuating gender inequalities. However, the influence of the general practitioner's (GP's) sex on the prescription of antidepressants has not been adequately assessed in previous work and remains unclear. This retrospective cohort study aims to determine the influence of GP and patient sex on the treatment of major depression. Methods: The study population comprised 87,629 patients (33.56% male patients and 66.44% female patients) aged over 15 years newly diagnosed with major depression recorded between 2017 and 2019 in Catalonia, Spain. Logistic regression models were used to evaluate the effect of GP sex on the therapeutic strategy (i.e., whether antidepressants were prescribed at the first diagnostic visit). Cox proportional hazards models and survival analyses were conducted to compare, according to GP and patient sex, the probability that a patient would be prescribed an antidepressant at any time during the study period. Finally, a multiple linear regression analysis was performed to assess the pharmacological intensity of the treatment [monthly fluoxetine-equivalent defined daily dose (DDD)]. Results: Female patients were more likely to be prescribed an antidepressant at the time of diagnosis, both by male [OR = 1.11, 95% CI = (1.05, 1.17), p < 0.001] and female GPs [OR = 1.13, 95% CI = (1.09, 1.17), p < 0.001]. Similarly, female patients were 8% and 9% more likely than male patients to be prescribed an antidepressant from male [HR = 1.08, 95% CI = (1.05, 1.11), p < 0.001] and female GPs [HR = 1.09, 95% CI = (0.92, 1.07), p < 0.001], respectively, during the study period. Female GPs prescribed less antidepressants than male GPs: an average of 0.39 less monthly fluoxetine-equivalent DDD [β = -0.39, 95% CI = (0.10, -3.92), p < 0.001]. Discussion: Few differences are observed between male and female GPs regarding the therapeutic strategy and its intensity for the treatment of major depression. However, both male and female GPs are influenced by biases and stereotypes that entail differential antidepressant-prescribing behaviors in accordance with the sex of the patient and their characteristics.
Collapse
Affiliation(s)
- Elisabeth Jufresa-Blanch
- Department of Medicine and Life Sciences, Universitat Pompeu Fabra, Barcelona, Spain
- Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS), Barcelona, Spain
| | - Neus Carrilero
- Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS), Barcelona, Spain
- Department of Experimental and Health Sciences (DCEXS), Universitat Pompeu Fabra, Barcelona, Spain
- Institut de Recerca de l’Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
| | - Anna García-Altés
- Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS), Barcelona, Spain
- CIBER de Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain
- Institut d’Investigació Biomèdica (IIB Sant Pau), Barcelona, Spain
| |
Collapse
|
4
|
Manrique Rabelo CM, Rivas Sucari HC. [Repercussions of gender inequalities in the mental health of patients]. Aten Primaria 2023; 55:102527. [PMID: 36455399 PMCID: PMC9706618 DOI: 10.1016/j.aprim.2022.102527] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/22/2022] [Revised: 10/06/2022] [Accepted: 10/10/2022] [Indexed: 11/29/2022] Open
|
5
|
Jacques-Aviñó C, Medina-Perucha L, Young-Silva Y, Granés L, Lòpez-Jiménez T, Berenguera A. [Narratives on changes in health-related behaviours during lockdown in Spain according to gender]. GACETA SANITARIA 2023; 37:102296. [PMID: 36921453 DOI: 10.1016/j.gaceta.2023.102296] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/24/2022] [Revised: 01/16/2023] [Accepted: 01/17/2023] [Indexed: 03/14/2023]
Abstract
OBJECTIVE To explore experiences related to health-oriented behaviours during lockdown in the Spanish resident population from a gender perspective. METHOD Qualitative research with a critical and feminist approach. Twenty-nine semi-structured interviews (17 women and 12 men) were conducted between June and July 2020 via telephone with people who had previously answered an online survey. The interviews were transcribed and a thematic content analysis was carried out, differentiating between the experiences of women and men. The data were triangulated by the research team. RESULTS Among women, greater diversity emerged in terms of health behaviours. Among them, the difficult experiences related to COVID-19, the complexity of living together and doing unpaid care work, as well as the importance of support networks, stood out. Among men, there were different attitudes towards sport, self-care and having time for healthy eating were positively valued, and there was a good assessment of coexistence and organisation in household chores. In both men and women, work overload and economic problems were related to emotional distress and difficulties in carrying out healthy activities. CONCLUSIONS Health-oriented behaviours during lockdown differed according to gender. They were mostly limited to COVID-19 experiences, socio-economic conditions and burden of care. It is essential to tailor public health and primary care programmes according to people's life moments, taking into account their social context and questioning traditional gender roles.
Collapse
Affiliation(s)
- Constanza Jacques-Aviñó
- Fundació Institut Universitari per a la Recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, España; Universitat Autònoma de Barcelona, Bellaterra, Cerdanyola del Vallès (Barcelona), España; Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud (RICAPPS), España.
| | - Laura Medina-Perucha
- Fundació Institut Universitari per a la Recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, España; Universitat Autònoma de Barcelona, Bellaterra, Cerdanyola del Vallès (Barcelona), España; Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud (RICAPPS), España
| | - Yudy Young-Silva
- Fundació Institut Universitari per a la Recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Unitat de Suport a la Recerca Girona, Girona, España; Departament d'Infermeria, Universitat de Girona, Girona, España
| | - Laura Granés
- Servicio de Medicina Preventiva y Epidemiología, Hospital Clínic, Barcelona, España
| | - Tomás Lòpez-Jiménez
- Fundació Institut Universitari per a la Recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, España; Universitat Autònoma de Barcelona, Bellaterra, Cerdanyola del Vallès (Barcelona), España; Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud (RICAPPS), España
| | - Anna Berenguera
- Fundació Institut Universitari per a la Recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, España; Universitat Autònoma de Barcelona, Bellaterra, Cerdanyola del Vallès (Barcelona), España; Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud (RICAPPS), España; Departament d'Infermeria, Universitat de Girona, Girona, España
| |
Collapse
|